| Literature DB >> 28111599 |
Jean-Nicolas Desrosiers1, Xudong Wei1, Osvaldo Gutierrez2, Jolaine Savoie1, Bo Qu1, Xingzhong Zeng1, Heewon Lee1, Nelu Grinberg1, Nizar Haddad1, Nathan K Yee1, Frank Roschangar1, Jinhua J Song1, Marisa C Kozlowski2, Chris H Senanayake1.
Abstract
The direct arylation of pyridine substrates using non-precious catalysts is underdeveloped but highly desirable due to its efficiency to access important motifs while being extremely cost-effective. The first nickel-catalyzed C-3 direct arylation of pyridine derivatives to provide a new approach to valuable 1-azafluorene pharmacophore frameworks was developed. This transformation is accomplished using air-stable nickel catalyst precursors combined with phenanthroline ligands and tolerates a variety of substituents. Computational studies suggest facile oxidative addition via the pyridinium form, deprotonation, and a subsequent carbo-nickelation cyclization. Nickel homolysis/recombination permits isomerization to the stereochemical array needed for the final elimination.Entities:
Year: 2016 PMID: 28111599 PMCID: PMC5245920 DOI: 10.1039/C6SC01457G
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1Nickel-catalyzed C-3 direct arylation of pyridine derivatives.
Scheme 1Nickel-catalyzed C-3 direct arylation to generate 1-azafluorenes.
Optimization of direct arylation conditions
|
| ||||
| Entry | Ni source | Base | Ligand (mol%) | Yield |
| 1 | Ni(acac)2 | DBU | PPh3 (12) | 3 |
| 2 | (TMEDA)NiTolCl | DBU | PPh3 (12) | 7 |
| 3 | NiBr2 | DBU | PPh3 (12) | 9 |
| 4 | NiCl2(DME) | DBU | PPh3 (12) | 21 |
| 5 | NiCl2(DME) | DBU |
| 45 |
| 6 | NiCl2(DME) | DBU |
| 69 |
| 7 | NiCl2(DME) | DBU | Terpyridine (6) | 13 |
| 8 | NiCl2(DME) | DBU | 2,2′-Bipyridine (6) | 70 |
| 9 | NiCl2(DME) | NaOAc |
| 0 |
| 10 | NiCl2(DME) | KOAc |
| 38 |
| 11 | NiCl2(DME) | K2CO3 |
| 75 |
| 12 | NiCl2(DME) | DBU |
| 98 |
| 13 | NiCl2(DME) | DBU |
| 92 |
| 14 | NiCl2(DME) | DBU |
| 32 |
| 15 | NiCl2(DME) | DBU |
| 57 |
| 16 | NiCl2(DME) | DBU |
| 87 |
| 17 | NiCl2(DME) | DBU |
| 22 |
| 18 | NiCl2(DME) | DBU |
| 12 |
|
| ||||
Reaction conditions: Ni catalyst (5 mol%), ligand (6–12 mol%), base (5.0 equiv.) in DMF at 120 °C.
HPLC assay % yield determined by using a calibration curve.
binap = 2,2′-bis(diphenyl-phosphino)-1,1′-binapthalene.
iPr-pybox = 2,6-bis[isopropyl-2-oxazolin-2-yl]pyridine.
Scheme 2Reaction scope of C-3 arylation of pyridinium ions. Reaction conditions: Ni catalyst (5 mol%), 1,10-phenanthroline (6 mol%), DBU (5.0 equiv.) in DMF at 120 °C for 1–12 h; isolated yield determined after flash chromatography. Determined by 1H NMR assay yield using dimethyl fumarate as an internal standard.
Scheme 3Deprotection and hydrogenation of protected 1-azafluorene.
Fig. 2Cyclization pathways commencing from neutral dihydripyridine (free energies are given in kcal mol–1 for calculations with UM06/6-311+G(d,p)-SMD-nitromethane//UB3LYP/6-31G(d)-gas).
Fig. 3Cyclization pathways commencing from the pyridinium ion. Free energies are given in kcal mol–1 for calculations with UM06/6-311+G(d,p)-SMD-nitromethane//UB3LYP/6-31G(d)-gas phase.
Scheme 4Overall mechanism of the pyridinium direct arylation.